Neurophysiology of Disjunctive Saccades
- Institution
- University of Washington, WA
- Principal investigator
- Mark M Walton
- Funding
- $848K
- Duration
- 2024–2029
Moonbase score
Still being scored
Abstract
ABSTRACT For more than 100 years much of oculomotor research in primates has been guided by Hering's law, which states that any eye movement generated by the brain will be sent equally to the two eyes so that they move as a yoked pair. Refixations between targets in different directions involve saccades, which are conjugate movements that have peak velocities of hundreds of degrees per second. Refixations between targets at different distances require vergence eye movements, which slowly rotate the eyes by equal amounts in opposite directions. For gaze shifts between targets that differ in both direction and distance, vergence velocity is substantially higher during the saccade. The neural basis for this effect has been the subject of intense debate for more than 35 years. According to one view, consistent with Hering's Law, the extremely high intrasaccaddic vergence velocity results from a non-linear interaction between saccades and vergence. Alternatively, the vergence angle changes rapidly during the saccade because the saccadic system programs unequal saccades. This latter view would be inconsistent with Hering's law, since it necessitates the generation of unequal saccadic commands. For this reason, virtually all of the relevant neurophysiological studies have targeted brain areas involved in the generation of saccadic eye movements. The existing literature has yielded conflicting results, which is why this problem remains controversial. The experiments in this proposal take a novel approach, primarily by targeting brain areas involved in the generation of vergence eye movements during both slow vergence and disjunctive saccades.
LOADING MOONBASE SCORE
Questions for University of Washington
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · University of Washington66
NextGen Long-acting and targeted combination ART for Children with HIV
Rodney J.Y. Ho · $1.4M · 2020–2026
- NIH · University of Washington63
TLR7/8 agonist design and delivery for effective anticancer immune response
Jayanth Panyam · $350K · 2021–2026
- NIH · University of Washington63
Rare Mutations and Autism Spectrum Disorders
Evan Eichler · $758K · 2013–2026